Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
DexTech Medical | DEX | May 15, 2024 | 4.40 | -3.51 |
Diagonal Bio | DIABIO | May 15, 2024 | 0.03 | -46.80 |
Diamyd Medical B | DMYDB | May 15, 2024 | 13.18 | +14.61 |
Dicot | DICOT | May 15, 2024 | 0.26 | +0.20 |
Double Bond Pharmaceutical B | DBPB | May 15, 2024 | 0.70 | -3.33 |
Ectin Research | ECTINB | May 15, 2024 | 0.45 | -2.62 |
Egetis Therapeutics | EGTX | May 15, 2024 | 6.72 | +9.62 |
Elicera Therapeutics | ELIC | May 15, 2024 | 0.85 | -5.12 |
Ellen | ELN | May 15, 2024 | 1.44 | +4.35 |
Enorama Pharma | ERMA | May 15, 2024 | 3.50 | +0.29 |
Enzymatica | ENZY | May 15, 2024 | 3.20 | -1.54 |
EQL Pharma | EQL | May 15, 2024 | 43.40 | +8.50 |
Eurocine Vaccines | EUCI | May 15, 2024 | 0.04 | -5.24 |
ExpreS2ion Biotech Holding | EXPRS2 | May 15, 2024 | 1.44 | -0.14 |
Fluicell | FLUI | May 15, 2024 | 0.09 | -2.75 |
Gabather | GABA | May 15, 2024 | 2.11 | -3.21 |
Genovis | GENO | May 15, 2024 | 31.95 | +9.61 |
Glycorex Transplantati.. | GTABB | May 15, 2024 | 0.98 | -1.41 |
Guard Therapeutics International | GUARD | May 15, 2024 | 39.00 | +1.56 |
Hamlet BioPharma AB (publ) | HAMLETB | May 15, 2024 | 4.20 | +3.19 |
Hansa Biopharma | HNSA | May 15, 2024 | 38.00 | +1.33 |
Hemply Balance | HMPLY | May 15, 2024 | 0.03 | -14.29 |
I-tech | ITECH | May 15, 2024 | 48.20 | -0.21 |
Immunovia | IMMNOV | May 15, 2024 | 1.55 | +1.84 |
InDex Pharmaceuticals Holding | INDEX | May 15, 2024 | 0.41 | +1.22 |
Infant Bacterial Therapeutics B | IBTB | May 15, 2024 | 97.80 | -1.21 |
Initiator Pharma | INIT | May 15, 2024 | 9.30 | -0.64 |
Intervacc | IVACC | May 15, 2024 | 4.37 | -7.02 |
IRLAB Therapeutics A | IRLABA | May 15, 2024 | 15.75 | -2.78 |
Isofol Medical | ISOFOL | May 15, 2024 | 0.70 | +0.14 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.